11
18
Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T77075 |
Spartalizumab
PDR001 |
PD-1/PD-L1 | Apoptosis; Cell Cycle/Checkpoint; Immunology/Inflammation |
Spartalizumab (PDR001) 是一种人源化的免疫球蛋白 4 单克隆抗体,在低浓度下选择性与 PD-1结合显示出较高活性。Spartalizumab 阻断与 PD-L1 和 PD-L2 的相互作用,可用于研究甲状腺未分化癌 (ATC)。 | |||
T9902 |
Atezolizumab
阿特朱单抗,阿特珠单抗 |
Apoptosis; PD-1/PD-L1; Autophagy | Apoptosis; Autophagy; Cell Cycle/Checkpoint; Immunology/Inflammation |
Atezolizumab 是一种人源化单克隆抗体 IgG1,能抵抗程序性死亡因子配体1 ,可用于癌症研究。 | |||
T35394 |
Sintilimab (anti-PD-1)
IBI308,Sintilimab (anti-PD-1) |
PD-1/PD-L1 | Apoptosis; Cell Cycle/Checkpoint; Immunology/Inflammation |
Sintilimab (IBI308) 是一种人源化的 IgG4 单克隆抗体,具有显著的抗肿瘤活性,通过与 PD-1 结合从而阻断 PD-1 与其配体 (PD-L1 和 PL-L2) 的相互作用,进而恢复内源性抗肿瘤 T 细胞反应。Sintilimab 联合其他化合物来治疗经典霍奇金淋巴瘤、非小细胞肺癌和食管癌。 | |||
T76850 | Dostarlimab | ||
Dostarlimab (TSR-042) 是一种人源化抗PD-1单克隆抗体。Dostarlimab 与人PD-1具有高亲和力,并竞争性地抑制其与其配体PD-L1和 PD-L2 的相互作用,IC50s 分别为 1.8 nM 和 1.5 nM。 | |||
T77023 | Geptanolimab | ||
Geptanolimab (CBT-501) 为一种针对程序性死亡-1 (PD-1) 的人源化 IgG4κ 单克隆抗体。通过竞争性抑制 PD-L1/L2 与 PD-1 的结合,Geptanolimab 在癌症研究中发挥作用。 | |||
TP1075 |
AUNP-12 TFA (1353563-85-5 free base)
AUNP-12 TFA,NP-12 TFA |
||
AUNP-12 TFA (NP-12 TFA) is a polypeptide antagonist in the pd-1 signaling pathway, which has the same antagonistic effect on pd-l1 and pd-l2, and can protect the proliferation and effector function of lymphocytes. | |||
T77003 | Ezabenlimab | ||
Ezabenlimab (BI-754091) 是一种抗PD-1单克隆抗体,结合PD-1的 Kd 为 6 nM (CHO 细胞)。Ezabenlimab 能够阻断PD-1与PD-L1和PD-L2的相互作用。Ezabenlimab 还增加 T 细胞内的 γ 干扰素分泌,抑制体内肿瘤生长。 | |||
T76985 | Tebotelimab | ||
Tebotelimab (MGD-013) 是一种人源的 IgG4κ 双特异性 PD-1/LAG-3双亲和再靶向 (DART) 抗体。Tebotelimab 结合 NS0 细胞表面表达的 PD-1和 LAG-3,EC50分别为 1.65 nM 和 0.41 nM。Tebotelimab 阻断 PD-1/PD-L1、PD-1/PD-L2 和 LAG-3/HLA (MHC-II) 相互作用和 PD-1信号。Tebotelimab 可恢复耗尽的 T 细胞功能并增强抗肿瘤免疫力。 | |||
T76945 | Cetrelimab | ||
Cetrelimab (JNJ 63723283; JNJ 3283) 为人源化IgG4κ单克隆抗体,专门针对PD-1。其与PD-1的结合Kd值为1.72 nM(在HEK293细胞中测得)。Cetrelimab有效阻断PD-1与其配体PD-L1和PD-L2的结合,其IC50值分别为111.7 ng/mL与138.6 ng/mL。此外,Cetrelimab能激活外周T细胞,提升细胞因子(IFN-γ, IL-2, TNF-α)的表达水平,进而抑制肿瘤在体内的生长。 | |||
T76020 |
AUNP-12 TFA
|
||
AUNP-12 (NP-12) TFA 是 PD-1信号通路的一种多肽拮抗剂,在抑制淋巴细胞增殖和效应功能方面对 PD-L1和 PD-L2 具有等效的拮抗作用。AUNP-12 TFA 具有免疫激活作用、良好的抗肿瘤活性,具有更好的研究免疫相关不良事件 (irAEs) 的潜力。 | |||
T35396 | Spartalizumab (anti-PD-1) | PD-1/PD-L1 | Apoptosis; Cell Cycle/Checkpoint; Immunology/Inflammation |
Spartalizumab (anti-PD-1)是一种针对PD-1的人源IgG4抗体,抑制PD-L1和PD-L2与PD-1的结合。PDR001可与PD-1以高亲和力结合,抑制其生物活性;MW: 145.8 KD。 |
Cat. No. | Product Name | Species | Expression System |
---|---|---|---|
TMPY-04957 |
PD-L2 Protein, Human, Recombinant (His), Biotinylated
B7DC,Btdc,B7-DC,bA574F11.2,PDL2,programmed... |
Human | HEK293 Cells |
PD-L2 Protein, Human, Recombinant (His), Biotinylated is expressed in HEK293 mammalian cells with His tag. The predicted molecular weight is 24 kDa and the accession number is Q9BQ51-1. | |||
TMPY-05827 |
PD-L2 Protein, Human, Recombinant (mFc)
PDCD1L2,bA574F11.2,Btdc,B7-DC,PD-... |
Human | HEK293 Cells |
PD-L2 Protein, Human, Recombinant (mFc) is expressed in HEK293 mammalian cells with mFc tag. The predicted molecular weight is 48.93 kDa and the accession number is Q9BQ51-1. | |||
TMPY-04346 |
PD-L2 Protein, Human, Recombinant (His)
PD-L2,B7-DC,CD273,Btdc,PDCD1L... |
Human | HEK293 Cells |
PD-L2 Protein, Human, Recombinant (His) is expressed in HEK293 mammalian cells with His tag. The predicted molecular weight is 24 kDa and the accession number is Q9BQ51-1. | |||
TMPY-02436 |
PD-L2 Protein, Mouse, Recombinant (hFc)
F730015O22Rik,Btdc,PD-L2,programmed cell d... |
Mouse | HEK293 Cells |
PD-L2 Protein, Mouse, Recombinant (hFc) is expressed in HEK293 mammalian cells with hFc tag. The predicted molecular weight is 49.5 kDa and the accession number is Q9WUL5. | |||
TMPY-02352 |
PD-L2 Protein, Mouse, Recombinant (His)
programmed cell death 1 ligand 2,Btdc,F730015O22Rik,B7-DC, |
Mouse | HEK293 Cells |
PD-L2 Protein, Mouse, Recombinant (His) is expressed in HEK293 mammalian cells with His tag. The predicted molecular weight is 24 kDa and the accession number is Q9WUL5. | |||
TMPY-05282 |
PD-L2 Protein, Mouse, Recombinant (His), Biotinylated
PD-L2,programmed cell death 1 ligand 2,B7-... |
Mouse | HEK293 Cells |
PD-L2 Protein, Mouse, Recombinant (His), Biotinylated is expressed in HEK293 mammalian cells with His tag. The predicted molecular weight is 24 kDa and the accession number is Q9WUL5. | |||
TMPY-00120 |
PD-L2 Protein, Human, Recombinant (hFc)
Btdc,B7-DC,programmed cell death 1 ligand 2,B7DC,PD... |
Human | HEK293 Cells |
PD-L2 Protein, Human, Recombinant (hFc) is expressed in HEK293 mammalian cells with hFc tag. The predicted molecular weight is 49.3 kDa and the accession number is Q9BQ51-1. | |||
TMPK-00166 |
PD-L2 Protein, Human, Recombinant (His & Avi)
PDL2,Btdc,Butyrophilin B7-DC,PDCD... |
Human | HEK293 Cells |
PD-1 ligand 2 (PD-L2) as a second ligand for PD-1 and compare the function and expression of PD-L1 and PD-L2. Engagement of PD-1 by PD-L2 dramatically inhibits T cell receptor (TCR)-mediated proliferation and cytokine production by CD4 T cells. At low antigen concentrations, PD-L2-PD-1 interactions inhibit strong B7-CD28 signals. PD-L2 Protein, Human, Recombinant (His & Avi) is expressed in HEK293 mammalian cells with C-His-Avi tag. The predicted molecular weight is 25.3 kDa and the accession nu... | |||
TMPK-01290 |
PD-L2 Protein, Cynomolgus, Recombinant (aa 20-220, His)
B7DC,PDL2,CD273, PDCD1 ligand 2,B... |
Cynomolgus | HEK293 Cells |
PD-1 ligand 2 (PD-L2) as a second ligand for PD-1 and compare the function and expression of PD-L1 and PD-L2. Engagement of PD-1 by PD-L2 dramatically inhibits T cell receptor (TCR)-mediated proliferation and cytokine production by CD4 T cells. At low antigen concentrations, PD-L2-PD-1 interactions inhibit strong B7-CD28 signals. PD-L2 Protein, Cynomolgus, Recombinant (aa 20-220, His) is expressed in HEK293 mammalian cells with C-His tag. The predicted molecular weight is 23.73 kDa and the acces... | |||
TMPY-06281 |
PD-L2 Protein, Human, Recombinant (hFc & Avi), Biotinylated
bA574F11.2,B7DC,B7-DC,PDCD1L2,programmed c... |
Human | HEK293 Cells |
PD-L2 Protein, Human, Recombinant (hFc & Avi), Biotinylated is expressed in HEK293 mammalian cells with hFc and Avi tag. The predicted molecular weight is 51.09 kDa and the accession number is Q9BQ51-1. | |||
TMPY-05613 |
PD-L2 Protein, Human, Recombinant (His & Avi), Biotinylated
bA574F11.2,programmed cell death 1 ligand 2,Btdc,PD... |
Human | HEK293 Cells |
PD-L2 Protein, Human, Recombinant (His & Avi), Biotinylated is expressed in HEK293 mammalian cells with His and Avi tag. The predicted molecular weight is 25.8 kDa and the accession number is Q9BQ51-1. | |||
TMPY-04223 |
PD-L2 Protein, Rat, Recombinant (hFc)
programmed cell death 1 ligand 2 |
Rat | HEK293 Cells |
PD-L2 Protein, Rat, Recombinant (hFc) is expressed in HEK293 mammalian cells with hFc tag. The predicted molecular weight is 49.2 kDa and the accession number is D4AAV6. | |||
TMPY-03738 |
PD-L2 Protein, Cynomolgus, Recombinant (His)
programmed cell death 1 ligand 2 |
Cynomolgus | HEK293 Cells |
PD-L2 Protein, Cynomolgus, Recombinant (His) is expressed in HEK293 mammalian cells with His tag. The predicted molecular weight is 24 kDa and the accession number is A4GW30. | |||
TMPY-04225 |
PD-L2 Protein, Rat, Recombinant (His)
programmed cell death 1 ligand 2 |
Rat | HEK293 Cells |
PD-L2 Protein, Rat, Recombinant (His) is expressed in HEK293 mammalian cells with His tag. The predicted molecular weight is 23.9 kDa and the accession number is D4AAV6. | |||
TMPY-03404 |
PD-L2 Protein, Cynomolgus, Recombinant (hFc)
programmed cell death 1 ligand 2 |
Cynomolgus | HEK293 Cells |
PD-L2 Protein, Cynomolgus, Recombinant (hFc) is expressed in HEK293 mammalian cells with hFc tag. The predicted molecular weight is 49.6 kDa and the accession number is A4GW30. | |||
TMPY-06819 |
PD-L2 Protein, Rhesus, Recombinant (hFc)
programmed cell death 1 ligand 2 |
Rhesus | HEK293 Cells |
PD-L2 Protein, Rhesus, Recombinant (hFc) is expressed in HEK293 mammalian cells with hFc tag. The predicted molecular weight is 49.6 kDa and the accession number is A4GW30. | |||
TMPY-06838 |
PD-L2 Protein, Rhesus, Recombinant (His)
programmed cell death 1 ligand 2 |
Rhesus | HEK293 Cells |
PD-L2 Protein, Rhesus, Recombinant (His) is expressed in HEK293 mammalian cells with His tag. The predicted molecular weight is 24 kDa and the accession number is NP_001077068.1. | |||
TMPJ-00181 |
PD-1 Protein, Human, Recombinant (His & Avi), Biotinylated
Programmed cell death protein 1,PDCD1,CD279,hPD... |
Human | HEK293 Cells |
Programmed cell death protein 1(PDCD1) is a single-pass type I membrane protein and contains 1 Ig-like V-type domain. PD-1 is a member of the extended CD28/CTLA-4 family of T cell regulators. PDCD1 inhibits the T-cell proliferation and production of related cytokines including IL-1, IL-4, IL-10 and IFN-γ by suppressing the activation and transduction of PI3K/AKT pathway. In addition, coligation of PDCD1 inhibits BCR-mediating signal by dephosphorylating key signal transducer. PDCD1 has been sugg... |